Literature DB >> 5481703

Daunomycin metabolism in rat tissue slices.

N R Bachur, J C Cradock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5481703

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  13 in total

1.  Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma.

Authors:  N Baldini; K Scotlandi; M Serra; K Kusuzaki; T Shikita; M C Manara; D Maurici; M Campanacci
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  Pharmacogenomics in pediatric leukemia.

Authors:  Steven W Paugh; Gabriele Stocco; William E Evans
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

3.  Subcutaneous transposition of the spleen: pharmacokinetic study of the intrasplenic route.

Authors:  F Noguerales; M A Dapena; F Requena; M T Blanco; F Galeano; J J Dorado; L Garcia-Sancho
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

4.  NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.

Authors:  N R Bachur; S L Gordon; M V Gee; H Kon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Modification of adriamycin toxicity in rats fed a high fat diet.

Authors:  G Zbinden; E Brändle; M Pfister
Journal:  Agents Actions       Date:  1977-03

6.  Uptake and metabolism of daunorubicin by human myelocytic cells.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines.

Authors:  Y Wollman; I Shahar; M Goldstein; J Leibovici
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.

Authors:  D L de Valeriola; D D Ross; A Forrest; D P Cuddy; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

10.  Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.

Authors:  G M Hahn; J Braun; I Har-Kedar
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.